These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15769549)

  • 1. Glycosaminoglycans inhibit neurodegenerative effects of serum amyloid P component in vitro.
    Urbányi Z; Forrai E; Sárvári M; Likó I; Illés J; Pázmány T
    Neurochem Int; 2005 May; 46(6):471-7. PubMed ID: 15769549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid P component induces TUNEL-positive nuclei in rat brain after intrahippocampal administration.
    Urbányi Z; Sass M; Laszy J; Takács V; Gyertyán I; Pázmány T
    Brain Res; 2007 May; 1145():221-6. PubMed ID: 17337265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms.
    Pisalyaput K; Tenner AJ
    J Neurochem; 2008 Feb; 104(3):696-707. PubMed ID: 17986223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
    Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
    Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of rhubarb derivatives on amyloid beta (1-42) peptide-induced apoptosis in IMR-32 cells: a case of nutrigenomic.
    Misiti F; Sampaolese B; Mezzogori D; Orsini F; Pezzotti M; Giardina B; Clementi ME
    Brain Res Bull; 2006 Dec; 71(1-3):29-36. PubMed ID: 17113925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity.
    Caraci F; Chisari M; Frasca G; Canonico PL; Battaglia A; Calafiore M; Battaglia G; Bosco P; Nicoletti F; Copani A; Sortino MA
    Brain Res; 2005 Jun; 1047(1):30-7. PubMed ID: 15882840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etazolate, a neuroprotective drug linking GABA(A) receptor pharmacology to amyloid precursor protein processing.
    Marcade M; Bourdin J; Loiseau N; Peillon H; Rayer A; Drouin D; Schweighoffer F; Désiré L
    J Neurochem; 2008 Jul; 106(1):392-404. PubMed ID: 18397369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
    Cho S; Hu Y
    Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of Toki-shakuyaku-san on amyloid beta25-35-induced neuronal damage in cultured rat cortical neurons.
    Egashira N; Iwasaki K; Akiyoshi Y; Takagaki Y; Hatip-Al-Khatib I; Mishima K; Kurauchi K; Ikeda T; Fujiwara M
    Phytother Res; 2005 May; 19(5):450-3. PubMed ID: 16106382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation.
    Webster S; Glabe C; Rogers J
    Biochem Biophys Res Commun; 1995 Dec; 217(3):869-75. PubMed ID: 8554610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an extended interacting surface between beta-amyloid and serum amyloid P component.
    Likó I; Mák M; Klement E; Hunyadi-Gulyás E; Pázmány T; Medzihradszky KF; Urbányi Z
    Neurosci Lett; 2007 Jan; 412(1):51-5. PubMed ID: 17141957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalpol attenuates the neurotoxicity induced by beta-amyloid(1-42) in cortical neuron-glia cultures.
    Jiang B; Du J; Liu JH; Bao YM; An LJ
    Brain Res; 2008 Jan; 1188():139-47. PubMed ID: 18022141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
    Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
    J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overactivation of calcineurin induced by amyloid-beta and prion proteins.
    Agostinho P; Lopes JP; Velez Z; Oliveira CR
    Neurochem Int; 2008 May; 52(6):1226-33. PubMed ID: 18295934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation.
    Familian A; Boshuizen RS; Eikelenboom P; Veerhuis R
    Glia; 2006 Feb; 53(3):233-40. PubMed ID: 16220550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons.
    Hirata K; Yamaguchi H; Takamura Y; Takagi A; Fukushima T; Iwakami N; Saitoh A; Nakagawa M; Yamada T
    J Pharmacol Exp Ther; 2005 Jul; 314(1):252-9. PubMed ID: 15798005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.
    Leschik J; Welzel A; Weissmann C; Eckert A; Brandt R
    J Neurochem; 2007 Jun; 101(5):1303-15. PubMed ID: 17298384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.
    Arancibia S; Silhol M; Moulière F; Meffre J; Höllinger I; Maurice T; Tapia-Arancibia L
    Neurobiol Dis; 2008 Sep; 31(3):316-26. PubMed ID: 18585459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.